Share this article on:

TOUCH® PRO Study: The Impact of Natalizumab on Utilization of Healthcare Resources by the Patients and Their Associated Treatment Satisfaction: P‐65

Rubin, David1; Nag, Arpita2; Taylor, Lori3; Hogge, Gary4; Kane, Sunanda5; Lewis, James6; Panaccione, Remo7; Colombel, Jean‐Frédéric8

Inflammatory Bowel Diseases: December 2012 - Volume 18 - Issue - p S42
Abstracts from the 2012 Advances in Inflammatory Bowel Diseases Crohn's & Colitis Foundation's National Clinical & Research Conference December 13-15, 2012 Hollywood, Florida: Clinical Poster Presentations